News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,180 Results
Type
Article (8045)
Company Profile (140)
Press Release (477994)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166830)
Career Advice (311)
Deals (25757)
Drug Delivery (7)
Drug Development (52900)
Employer Resources (15)
FDA (9797)
Job Trends (8580)
News (238340)
Policy (17921)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33165)
ALS (107)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (280)
Approvals (10438)
Artificial intelligence (330)
ASCO (159)
Autoimmune disease (218)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6962)
BIO (36)
Biologics (9)
BIOSECURE Act (2)
Biosimilars (115)
BioSpace Insights (18)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (517)
Cancer (3741)
Cardiovascular disease (229)
Career advice (251)
Career pathing (2)
CAR-T (178)
CDMO (13)
Celiac Disease (1)
Cell therapy (485)
Cervical cancer (35)
Clinical research (48024)
Collaboration (1275)
Commercialization (4)
Compensation (1524)
Complete response letters (35)
COVID-19 (758)
CRISPR (64)
C-suite (797)
Cystic fibrosis (87)
Data (5830)
Denatured (4)
Depression (104)
Dermatology (67)
Diabetes (352)
Diagnostics (4204)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (167)
Earnings (73792)
Editorial (1)
Employer branding (3)
Employer resources (15)
Events (88119)
Executive appointments (712)
FDA (12503)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (945)
Gene editing (126)
Generative AI (9)
Gene therapy (330)
GLP-1 (295)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9394)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (66)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (949)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (259)
Interviews (43)
IPO (12401)
IRA (2)
Job creations (1970)
Job search strategy (237)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Leadership (1)
Legal (5196)
Licensing (17)
Liver cancer (45)
Longevity (19)
Lung cancer (532)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (560)
Marketing (9)
MASH (118)
Medical affairs (3)
Medical device (8689)
Medtech (8844)
Mergers & acquisitions (14412)
Metabolic disorders (723)
mRNA (60)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1857)
NextGen: Class of 2026 (3155)
Non-profit (849)
Obesity (231)
Opinion (15)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (204)
Partnered (13)
Patents (492)
Patient recruitment (527)
Patient selection (1)
Peanut (32)
People (41347)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15521)
Phase 2 (21446)
Phase 3 (14455)
Pipeline (7640)
Policy (21)
Postmarket research (1570)
Preclinical (6553)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (587)
Real estate (3023)
Recruiting (6)
Regenerative medicine (1)
Regulatory (14939)
Reports (23)
Research institute (585)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (160)
Series B (126)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2023)
Stomach cancer (3)
Supply chain (53)
Tariffs (1)
Vaccines (333)
Venture capital (17)
Weight loss (75)
Women's health (86)
Date
Today (64)
Last 7 days (435)
Last 30 days (1354)
Last 365 days (19106)
2026 (13447)
2025 (19273)
2024 (23008)
2023 (26561)
2022 (34621)
2021 (37191)
2020 (33506)
2019 (23270)
2018 (17484)
2017 (18775)
2016 (17931)
2015 (24283)
2014 (21699)
2013 (18151)
2012 (20244)
2011 (20491)
2010 (20350)
Location
Africa (229)
Alabama (77)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17958)
Australia (2112)
California (12309)
Canada (3220)
China (543)
Colorado (494)
Connecticut (425)
Delaware (212)
Europe (24718)
Florida (1844)
Georgia (392)
Hawaii (3)
Idaho (46)
Illinois (723)
India (52)
Indiana (322)
Iowa (16)
Japan (418)
Kansas (102)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1227)
Massachusetts (8074)
Michigan (313)
Minnesota (569)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (120)
New Hampshire (60)
New Jersey (2683)
New Mexico (12)
New York (2883)
North Carolina (1312)
North Dakota (4)
Northern California (6181)
Ohio (292)
Oklahoma (14)
Oregon (16)
Pennsylvania (2292)
Puerto Rico (21)
Rhode Island (30)
South America (409)
South Carolina (77)
South Dakota (1)
Southern California (5130)
Tennessee (123)
Texas (1992)
United States (39880)
Utah (367)
Vermont (1)
Virginia (158)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
486,180 Results for "cadence inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Cadence Expands Pfizer’s License to Molecular Design Software
Cadence Molecular Sciences announced that Pfizer Inc. has signed an agreement to extend and expand access to Cadence® products and programming toolkits for advanced molecular design.
October 25, 2023
·
2 min read
Press Releases
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
March 30, 2026
·
14 min read
Deals
Cadence Announces the Acquisition of ARC Group Worldwide’s Florida Location
Cadence, Inc. announced that it has acquired the Florida location of ARC Group Worldwide, a precision manufacturer specializing in Metal Injection Molding and cleanroom plastic injection molding.
October 3, 2023
·
3 min read
BioCapital
Cadence Announces the Acquisition of Utitec, Inc.
Cadence, Inc., a leading contract manufacturer of medical and drug delivery devices and specialty commercial products, announced that it has acquired Utitec, Inc., a manufacturer specializing in miniature, deep drawn medical device and commercial components.
January 3, 2023
·
1 min read
Press Releases
Cadence Welcomes Bob White to Board of Directors
September 13, 2024
·
2 min read
Press Releases
Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF)
November 19, 2025
·
9 min read
Press Releases
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
June 17, 2025
·
1 min read
Deals
Cadence Completes Acquisition of OpenEye Scientific
Cadence Design Systems, Inc. (Nasdaq: CDNS) announced today that it has completed the acquisition of OpenEye Scientific Software, Inc. (“OpenEye”).
September 1, 2022
·
4 min read
BioForest
Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy
Cadence Neuroscience announced today that it has secured $26 million in Series B financing.
May 17, 2023
·
3 min read
Business
Cadence, Inc. Announces Appointment of Rob Werge as President and CEO
Cadence, Inc., a leading contract manufacturer of medical and drug delivery devices, is pleased to announce the appointment of Rob Werge as its new President and Chief Executive Officer.
May 3, 2022
·
2 min read
1 of 48,618
Next
